|
May 22
|
Sernova Biotherapeutics Appoints World-Class Clinical Advisory Board to Support Development of Cell Pouch Bio-hybrid Organ as Functional Cure for Type 1 Diabetes
|
|
Feb 3
|
Sernova Biotherapeutics Submits IND Application for its Cell Pouch Bio-Hybrid Organ with Autograft Thyroid Cells in Patients with Hypothyroidism
|
|
Dec 20
|
Sernova Reschedules its Annual General and Special Meeting of Shareholders to January 10, 2025
|